Does Rivaroxaban in Patients With AF Differ in Those With Prior MI?

A subgroup analysis of patients in the ROCKET-AF trial found rivaroxaban is equally effective in AF patients with prior MI as in those without. Read more here on results of the safety analysis and other data.
Source: Consultant Live - Category: Primary Care Source Type: news
More News: Primary Care